160 related articles for article (PubMed ID: 18193504)
1. Clinical study of cutaneous drug eruptions in 200 patients.
Raksha MP; Marfatia YS
Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of cutaneous drug eruptions in 200 patients.
Patel RM; Marfatia YS
Indian J Dermatol Venereol Leprol; 2008; 74(4):430. PubMed ID: 18810845
[TBL] [Abstract][Full Text] [Related]
3. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
Dharamsi FM; Michener MD; Dharamsi JW
J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
[TBL] [Abstract][Full Text] [Related]
4. Clinical pattern of cutaneous drug eruption among children and adolescents in north India.
Sharma VK; Dhar S
Pediatr Dermatol; 1995 Jun; 12(2):178-83. PubMed ID: 7659648
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
[TBL] [Abstract][Full Text] [Related]
6. Drugs causing fixed eruptions: a study of 450 cases.
Mahboob A; Haroon TS
Int J Dermatol; 1998 Nov; 37(11):833-8. PubMed ID: 9865869
[TBL] [Abstract][Full Text] [Related]
7. Adverse cutaneous drug reactions--a clinico-demographic study in a tertiary care teaching hospital of the Kashmir Valley, India.
Qayoom S; Bisati S; Manzoor S; Sameem F; Khan K
Arch Iran Med; 2015 Apr; 18(4):228-33. PubMed ID: 25841943
[TBL] [Abstract][Full Text] [Related]
8. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of skin reactions to NSAIDs.
Roujeau JC
Scand J Rheumatol Suppl; 1987; 65():131-4. PubMed ID: 2961055
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
[TBL] [Abstract][Full Text] [Related]
11. Risk of skin reactions when using ibuprofen-based medicines.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Expert Opin Drug Saf; 2005 Sep; 4(5):837-48. PubMed ID: 16111447
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
13. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
[TBL] [Abstract][Full Text] [Related]
14. [Drug eruptions in children in Cotonou, Benin].
Adegbidi H; Atadokpede F; Sagbo G; Koudoukpo C; D'Almeida M; Teclessou J; N'Dah P; Djoonyam A Eroume AT; Yedomon HG; Do Ango-Padonou F
Mali Med; 2012; 27(1):42-6. PubMed ID: 22947321
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
16. Fixed drug eruption associated with co-trimoxazole.
Mohamed KB
J Pediatr; 1999 Sep; 135(3):396. PubMed ID: 10484812
[No Abstract] [Full Text] [Related]
17. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lipowicz S; Sekula P; Ingen-Housz-Oro S; Liss Y; Sassolas B; Dunant A; Roujeau JC; Mockenhaupt M
Br J Dermatol; 2013 Apr; 168(4):726-32. PubMed ID: 23413807
[TBL] [Abstract][Full Text] [Related]
18. Fixed drug eruption due to ibuprofen.
Alvarez Santullano CV; Tover Flores V; De Barrio Fernández M; Tornero Molina P; Prieto Garcia A
Allergol Immunopathol (Madr); 2006; 34(6):280-1. PubMed ID: 17262932
[TBL] [Abstract][Full Text] [Related]
19. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Wolkenstein P; Chosidow O; Fléchet ML; Robbiola O; Paul M; Dumé L; Revuz J; Roujeau JC
Contact Dermatitis; 1996 Oct; 35(4):234-6. PubMed ID: 8957644
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
